News – Page 437 – Endpoints News

Moderna's stock plunges in premarket trading as Bancel promises company is in 'much better place' for FY23 deliveries

3 years ago

Texas CDMO is cutting 60% of staff as focus shifts to drug discovery, in-house candidates

3 years ago

Manufacturing roundup: Terumo Pharmaceutical Solutions expanding CDMO reach outside Japan; EUROAPI boosting ...

3 years ago

Updated: Citing efficacy, GSK halts UTI antibiotic trial early, plans to file for FDA approval next year

3 years ago

Small startup touts a PhIII success in rare 'butterfly skin' disease after an FDA hold routed shares

3 years ago

Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager

3 years ago

After pulling IPO plans, Artiva partners with Affimed to speed up NK cell therapy combo

3 years ago

'Do the right thing': Billionaire pushes struggling biotech to return cash to investors

3 years ago

Exscientia wants to bring its AI/ML approach into the world of biologics. It's starting with antibodies

3 years ago

Compass' single-dose psilocybin shows strong efficacy in PhII treatment-resistant depression trial

3 years ago

A Chicago biotech skips the IPO in favor of late-stage Series D for a PhIII Tourette drug

3 years ago

Drug R&D hurdles hamper another biotech as a Jeff Aronin upstart shuts down

3 years ago

A high flyer out of Flagship implodes — for the last time

3 years ago

Mysterious OrbiMed-backed biotech nears $100M in funding, hints at plans to go after ‘undruggable 3.0’

3 years ago

GSK touts record Shingrix sales as Zantac cases go to trial

3 years ago

What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision

3 years ago

#CPHI22: UPS Healthcare sounds off on the future and challenges of the supply chain

3 years ago

FDA warning letters detail issues for manufacturing sites in the US and India

3 years ago

Novo Nordisk drops two programs as it plots Wegovy comeback

3 years ago

Allogene Overland Biopharm completes Shanghai facility to manufacture CAR-T products

3 years ago

CVS, Walgreens and Walmart reach nearly $12B settlement over opioid epidemic

3 years ago

For months Biden has touted his win over pharma in the election lead-up. Will it help?

3 years ago

Surface Oncology lays off 20% as biotech halts CD39 work on one of its ‘crown jewels’

3 years ago

In spinning out cancer pipeline, Alkermes cites Inflation Reduction Act's hypothetical incentives for biologics R&D

3 years ago

First page Previous page 434 435 436437438 439 440 Next page Last page